JPS56142213A - Pharmacuetical blend for treating parkinsonism syndrome - Google Patents
Pharmacuetical blend for treating parkinsonism syndromeInfo
- Publication number
- JPS56142213A JPS56142213A JP3265881A JP3265881A JPS56142213A JP S56142213 A JPS56142213 A JP S56142213A JP 3265881 A JP3265881 A JP 3265881A JP 3265881 A JP3265881 A JP 3265881A JP S56142213 A JPS56142213 A JP S56142213A
- Authority
- JP
- Japan
- Prior art keywords
- pharmacuetical
- blend
- treating parkinsonism
- parkinsonism syndrome
- syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19803008993 DE3008993A1 (de) | 1980-03-08 | 1980-03-08 | Pharmazeutische zubereitungen |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS56142213A true JPS56142213A (en) | 1981-11-06 |
Family
ID=6096652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3265881A Pending JPS56142213A (en) | 1980-03-08 | 1981-03-09 | Pharmacuetical blend for treating parkinsonism syndrome |
Country Status (5)
Country | Link |
---|---|
US (1) | US4331687A (ja) |
EP (1) | EP0035597B1 (ja) |
JP (1) | JPS56142213A (ja) |
AT (1) | ATE8739T1 (ja) |
DE (2) | DE3008993A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0708639A4 (en) * | 1992-06-23 | 1997-08-20 | Sepracor Inc | METHOD AND COMPOSITIONS FOR TREATMENT OF DEPRESSION AND OTHER DISEASES USING OPTICALLY PURE SIBUTTRAMINE |
AU4542893A (en) * | 1992-06-23 | 1994-01-24 | Sepracor, Inc. | Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine |
US5961987A (en) * | 1996-10-31 | 1999-10-05 | University Of Iowa Research Foundation | Ocular protein stimulants |
CA2289522A1 (en) * | 1997-05-27 | 1998-12-03 | Akzo Nobel Nv | Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits |
US6476078B2 (en) | 1999-08-11 | 2002-11-05 | Sepracor, Inc. | Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction |
US6974838B2 (en) | 1998-08-24 | 2005-12-13 | Sepracor Inc. | Methods of treating or preventing pain using sibutramine metabolites |
US6331571B1 (en) | 1998-08-24 | 2001-12-18 | Sepracor, Inc. | Methods of treating and preventing attention deficit disorders |
US6339106B1 (en) | 1999-08-11 | 2002-01-15 | Sepracor, Inc. | Methods and compositions for the treatment and prevention of sexual dysfunction |
US6399826B1 (en) | 1999-08-11 | 2002-06-04 | Sepracor Inc. | Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain |
WO2002083631A1 (en) | 2001-04-13 | 2002-10-24 | Sepracor Inc. | Methods of preparing didesmethylsibutramine and other sibutramine derivatives |
WO2018020366A1 (en) | 2016-07-26 | 2018-02-01 | Glaxosmithkline Intellectual Property (No.2) Limited | Crystalline (r)-mandelate salt of (1r,2s)-2-phenylcyclopropylamine |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2997422A (en) * | 1959-01-09 | 1961-08-22 | Smith Kline French Lab | Monoamine oxidase inhibition |
GB1438268A (en) | 1974-03-25 | 1976-06-03 | Nelson Research Dev Co | Antidepressant |
-
1980
- 1980-03-08 DE DE19803008993 patent/DE3008993A1/de not_active Withdrawn
- 1980-12-12 EP EP80107848A patent/EP0035597B1/de not_active Expired
- 1980-12-12 DE DE8080107848T patent/DE3068820D1/de not_active Expired
- 1980-12-12 AT AT80107848T patent/ATE8739T1/de not_active IP Right Cessation
-
1981
- 1981-03-03 US US06/240,161 patent/US4331687A/en not_active Expired - Lifetime
- 1981-03-09 JP JP3265881A patent/JPS56142213A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0035597A3 (en) | 1982-01-27 |
EP0035597A2 (de) | 1981-09-16 |
EP0035597B1 (de) | 1984-08-01 |
DE3068820D1 (en) | 1984-09-06 |
ATE8739T1 (de) | 1984-08-15 |
DE3008993A1 (de) | 1981-10-01 |
US4331687A (en) | 1982-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1555025A3 (en) | Use of dehydroepiandrosterone analogs for the treatment of asthma | |
HU9402771D0 (en) | Pharmaceutical compositions for wound healing and treatment of fibrotic disorders | |
HUT51136A (en) | Process for producing pharmaceutical compositions for treating schisophreny, containing l-deprenil as active component | |
DE3365465D1 (en) | Oral galenical forms of mopidamol | |
NZ303372A (en) | Use of (s)-oxybutynin and (s)-desethyloxybutynin to treat urinary incontinence | |
EP0147761A3 (en) | Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer | |
JPS56142213A (en) | Pharmacuetical blend for treating parkinsonism syndrome | |
DE3683586D1 (de) | Behandlung des atemunwohlseinsyndroms bei erwachsenen. | |
PT97785A (pt) | Metodo para a tratamento da impotencia utilizando, por exemplo, doxazosina | |
ES482097A1 (es) | Procedimiento para preparar derivados acilicos de carnitina. | |
ES8507567A1 (es) | Metodo para estabilizar un concentrado de gamma globulina | |
ATE137965T1 (de) | Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege | |
RO117760B1 (ro) | Metodă pentru tratamentul unei afecţiuni de neurotransmisie serotoninergică defectivă | |
DE3270806D1 (en) | (+)-2-(1-(2,6-dichlorophenoxy)-ethyl)-1,3-diazacyclopent-2-ene, process for its preparation and its use in pharmaceutical compositions | |
DE3478749D1 (en) | Covalently bound heparin - antithrombin-iii complex, method for its preparation and its use for treating thromboembolism | |
FR2533563B1 (ja) | ||
EP0100516A3 (en) | 3-beta-(3'-(carboxypropionyloxy))-ursa-9(11),12-dience-28-carboxylic acid and its salts, process for its preparation and medicines containing these compounds | |
ATE213634T1 (de) | Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts | |
DE602004021233D1 (de) | Herabgesetzte dosis von tolterodin zur behandlung von harnwegserkrankungen | |
IL126795A0 (en) | Pyridyl- and pyrimidyl-piperazines in the treatment of substance abuse disorders | |
DE3275060D1 (en) | Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs | |
YU44232B (en) | Process for obtaining alcalic salts of pyroxicame excreted onto pharmaceutical acceptable carrier | |
GB2019720A (en) | S-adenosyl-L-homocysteine and salts thereof for use in therapy | |
SU1197669A1 (ru) | Способ лечени нагноительных заболеваний легких | |
DE69736955D1 (de) | Verfahren und zusammensetzungen zur vorbeugung und behandlung von sodbrennen |